Concerns regarding in vitro and in vivo uses of thalidomide.
Tadesse
Azeb
A
Shannon
E J
EJ
D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects*; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*
D007917:Leprostatic Agents; D013792:Thalidomide